Literature DB >> 11017837

Two cases of human urinary tract infection complicated by hemolytic uremic syndrome caused by verotoxin-producing Escherichia coli.

F Scheutz1, B Olesen, A Nørgaard.   

Abstract

In 1993, 2 cases of urinary tract infection (UTI) caused by verotoxin-producing Escherichia coli were diagnosed at Rigshospitalet in Copenhagen, Denmark. Neither of the patients had any previous history of diarrhea. We suggest that E. coli strains isolated from UTI be examined for the production of verotoxin when hemolytic uremic syndrome is clinically suspected.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11017837     DOI： 10.1086/314019

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  8 in total

1.  Clinical isolates of non-O157 Shiga toxin-producing Escherichia coli: serotypes, virulence characteristics, and molecular profiles of strains of the same serotype.

Authors:  M Eklund; F Scheutz; A Siitonen
Journal:  J Clin Microbiol       Date:  2001-08       Impact factor: 5.948

2.  Hemolytic-uremic syndrome after Escherichia coli urinary tract infection in humans: systematic review of the literature.

Authors:  Dejan Lavrek; Sebastiano A G Lava; Gregorio P Milani; Giacomo D Simonetti; Mario G Bianchetti; Olivier Giannini
Journal:  J Nephrol       Date:  2018-10-17       Impact factor: 3.902

3.  Analysis of urinary Escherichia coli isolates for ability to produce Shiga toxin.

Authors:  James R Johnson; Catherine Jerome; Daniel R Boster; Ann E Stapleton; Phillip I Tarr
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

4.  Structural and genetic characterization of enterohemorrhagic Escherichia coli O145 O antigen and development of an O145 serogroup-specific PCR assay.

Authors:  Lu Feng; Sof'ya N Senchenkova; Jiang Tao; Alexander S Shashkov; Bin Liu; Sergei D Shevelev; Peter R Reeves; Jianguo Xu; Yuriy A Knirel; Lei Wang
Journal:  J Bacteriol       Date:  2005-01       Impact factor: 3.490

5.  lfnA from Pseudomonas aeruginosa O12 and wbuX from Escherichia coli O145 encode membrane-associated proteins and are required for expression of 2,6-dideoxy-2-acetamidino-L-galactose in lipopolysaccharide O antigen.

Authors:  Jerry D King; Erin F Mulrooney; Evgeny Vinogradov; Bernd Kneidinger; Kristen Mead; Joseph S Lam
Journal:  J Bacteriol       Date:  2007-12-21       Impact factor: 3.490

6.  Differences in virulence among Escherichia coli O157:H7 strains isolated from humans during disease outbreaks and from healthy cattle.

Authors:  Diane R Baker; Rodney A Moxley; Mike B Steele; Jeffrey T Lejeune; Jane Christopher-Hennings; Ding-Geng Chen; Philip R Hardwidge; David H Francis
Journal:  Appl Environ Microbiol       Date:  2007-09-21       Impact factor: 4.792

7.  Enterococcus raffinosus infection with atypical hemolytic uremic syndrome in a multiple myeloma patient after autologous stem cell transplant.

Authors:  Pankaj Mathur; Blake Hollowoa; Nupur Lala; Sharmilan Thanendrarajan; Aasiya Matin; Atul Kothari; Carolina Schinke
Journal:  Hematol Rep       Date:  2017-09-26

8.  Molecular characterization reveals similar virulence gene content in unrelated clonal groups of Escherichia coli of serogroup O174 (OX3).

Authors:  Cheryl L Tarr; Adam M Nelson; Lothar Beutin; Katharina E P Olsen; Thomas S Whittam
Journal:  J Bacteriol       Date:  2007-12-14       Impact factor: 3.490
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.